Member Info for Energyshares

This share has been researched to the hilt and a lot of good posters on this BB,too many to name have contributed to the Avacta education.

A few melts on here today trying their best to spread some negativity.

This is a Brucie Bonus today, trial funding until late 2024 and Diagnostics up and running with recurring income with all those Wetherby Diagnostic wages now being funded.
We don’t need to buy a manufacturer Launch diagnostics have access to 31 manufacturers.

Great bit of business by Avacta board.

Onwards Avacta. GLA

Launch Diagnostics is the largest independent distributor in the United Kingdom, providing pathology solutions encompassing high quality diagnostic reagents and instrumentation from world leading manufacturer’s to the Health Services of the United Kingdom, Belgium, Luxemburg, France through Launch Diagnostics SAS and to the Republic of Ireland through ACCUSAY Diagnostics.
Launch Diagnostics was established in 1990 and has been in business for more than 30 years.  It is one of the most successful privately owned companies in the United Kingdom’s diagnostics industry, being recognised by its customers and holding long term partnerships with many respected suppliers of diagnostic innovation.
Offering an extensive portfolio of products of diagnostic kits and laboratory instrumentation, our product range has expanded over the years to include a comprehensive range of EIA, single test devices, serology products, molecular assays and instrumentation.

They have access to 31 world class manufacturers
They don’t need to buy a manufacturer.

https://www.launchdiagnostics.com/about-us/

Go away Derek

They have a whole division of senior management sitting around for the last year. Now they can start earning their wages.

Great move especially if they want to sell diagnostics in the future.

GLA Market seems to like it moving back above £1

The funniest post today, everyone talking about the RNS’s and Wynbag in the middle of a essay misses the RNS and still talking about rumours :):):) couldn’t make it up

Avoid the noise keep hold of those golden tickets.

Avacta Therapeutics is today working with world-class cancer centres to advance our Phase I clinical program for AVA6000, a pioneering FAP-activated doxorubicin therapeutic harnessing Avacta’s pre|CISION™ platform. This first-in-class precision medicine offers the potential to significantly boost drug efficacy and minimise off-target toxicity by targeting the tumour microenvironment – with the ambition to revolutionise the treatability of solid tumours and transform outcomes for cancer patients.

Tom Mellows
Head of Developing & leasing Savills to Neil Bell. He helped Avacta with Lab move.

He Knows…

Neil, it was great to be at your launch this morning and to have supported you in the relocation from Cambridge down to White City...exciting times ahead!

Results to 31st Dec 2019
Page 17 last time they were mentioned.

MB53

Results to 31st Dec
Page 17 last time they were mentioned.

But no mention in Results to
31st Dec 2020
No RNS to say partnership ended to date.

Don’t worry Celtic
It’s Albert ‘s ball and he takes it home every night for tea and stops play.
It’s like a happy clapping church.

Truant sitting with Tom the Teeth at his Villa in Greece after the Avacta Blockbuster RNS

https://m.youtube.com/watch?v=ee925OTFBCA

Most researched company on AIM

GLA

Time Frame: Up to one year

Now 1 year and 65 days

It works just trying to find MTD ad seeing how well it works…..

1. Objective response rate (ORR) [ Time Frame: Up to one year ]ORR is defined as the proportion of patients achieving a best overall response of confirmed partial responses (PR) or complete response (CR), per Response Evaluation Criteria in Solid Tumors (RECIST 1.1).?
2. Duration of Response (DoR) [ Time Frame: Up to one year ]DoR is defined as the duration of time from date of first response to date of disease progression, as per RECIST v1.1?
3. Progression-free-survival (PFS) [ Time Frame: Up to one year ]PFS is defined as the time from the date of the first dose to the date of the first documentation of confirmed disease progression or death, whichever occurs first, as per RECIST v1.1?
4. Overall survival (OS) [ Time Frame: Up to one year ]Overall survival (OS), defined as the date of first dose) to the occurrence of death from any cause

Due to privacy regulations on LSE we can never use members name in chats.

Will the member who bores the f u.ck out of me everyday please have a
C hart attack.

How much does Avacta own of Affyxell
If its about 30% that’s about double of Avacta MCap now.

Anyone know Avacta split of Affyxell ?

Jupiter desperate trying to short small stocks they look in big trouble.
180 shorts opened against them.
9 pages :) :) :)

https://www.lse.co.uk/ShareChat.asp?ShareTicker=JUP&share=Jupiter-Fund-Management

Sheffield not yet recruiting
But they are advertising a consultant oncologist.

Description
University of Sheffield and Weston Park Cancer Centre in a ground breaking collaboration that will combine pioneering scientific and technological developments with a clear emphasis on improving cancer outcomes in the region.

“pioneering”where have we heard that recently.

DUTIES OF THE POST
The appointees will, together with Consultant colleagues be responsible for the provision of cancer services across Breast cancer & Head & Neck, Urology cancers and Melanoma

Listed as one of consultants on the post.
Dr R Young
Lung cancer, sarcoma, Germ cell tumours

AVA6000 trial
Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS.Principal Investigator: Dr Robin Young.

https://static1.squarespace.com/static/5dd4f8270fb5a0308e79b424/t/634001286da3e95d612f0370/1665138985312/Consultant+JD+with+on+call+element.pdf

Role on 1b

Bloody hell lse blocked tw an key

Cue the pantomime villain
Come on T****ey give us a lecture…..

I’m not naming other stocks but have a look around and AIM stocks have been taking a beating the last few months.
Avacta holding very well waiting on news…

GLA